Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Gynecol Obstet. 2014 Feb;289(2):237-9. doi: 10.1007/s00404-013-3114-3.

The heterogeneity of ovarian cancer.

Author information

1
Department of Gynecology and Obstetrics, University Hospital Aachen, PauwelsstraƟe 30, 52074, Aachen, Germany, imeinhold@ukaachen.de.

Abstract

Ovarian cancer carries the worst prognosis of all gynecological malignancies. This is mainly due to its resistance against commonly used cytostatic drugs as well as the lack of a screening method for its detection at an early stage. Both basic and translational research have shown over the past decades that ovarian cancer as a medical term includes several types of tumors with different phenotypes, molecular biology, etiology, tumor progression, and even different prognosis. In this issue of Archives of Gynecology and Obstetrics, J. Dietel presents a review article about novel findings of the etiopathogenesis of ovarian cancer and the role that fallopian tubes may play. He also outlines the implied clinical consequences. Here, we give a brief overview of the heterogeneity of ovarian cancer to introduce the topic.

PMID:
24318356
DOI:
10.1007/s00404-013-3114-3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center